AINDEX
Markets

Guardant Health, Inc. (GH)

GHNASDAQ-GSMedical Specialities

$142.45

-1.58 (-1.10%) today

Regular session, Nov 17, 10:58 AM ET

-1.10% 1D
Market cap
$19.27bn
P/E
–
EPS, last 4 quarters
$-3.67
Dividend yield
–
Day range
$141.25 to $148.96
52-week range
$74.55 to $191.05
Average volume
–
Previous close
$144.03

Analysts

20 covering

Buy19 buy, 1 hold, 0 sell

Targets a year out average $204.00, +43.2% from here

$180.00now $142.45$225.00

Earnings

next estimate $-0.7300

Next report

Dec 2025

-23.5%

Mar 2026

-19.7%

Jun 2026

-20.3%

Sep 2026

-36.8%

estimate reported, and the surprise

Financials

QuarterDec 2025Mar 2026Jun 2026Sep 2026
Revenue$281.27m$301.67m$334.98m$360.98m
Gross profit$181.77m$196.75m$219.03m$236.15m
Operating income-$120.81m-$121.35m-$129.12m-$132.76m
Net income-$128.49m-$112.08m-$120.14m-$124.36m

Last four quarters: revenue $1.28bn, margin -37.9%, free cash flow -$232.15m

News

8 latest

The company

Guardant Health is a leading precision oncology company focused on guarding wellness and giving every person more time free from cancer. Founded in 2012, Guardant is transforming patient care and accelerating new cancer therapies by providing critical insights into what drives disease through its advanced blood and tissue tests, real-world data and AI analytics. Guardant tests help improve outcomes across all stages of care, including screening to find cancer early, monitoring for recurrence in early-stage cancer, and treatment selection for patients with advanced cancer.

Sector
Health Care
Industry
Medical Specialities
Exchange
NASDAQ-GS
Region
North America

Often looked at with it

Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.